Luciano Cascione
Luciano Cascione
Institute of Oncology Research (IOR) - Bellinzona - Switzerland
Verified email at ior.usi.ch
TitleCited byYear
EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
M Garofalo, G Romano, G Di Leva, G Nuovo, YJ Jeon, A Ngankeu, J Sun, ...
Nature medicine 18 (1), 74, 2012
3702012
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer
N Valeri, C Braconi, P Gasparini, C Murgia, A Lampis, V Paulus-Hock, ...
Cancer cell 25 (4), 469-483, 2014
2062014
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation
G Romano, M Acunzo, M Garofalo, G Di Leva, L Cascione, C Zanca, ...
Proceedings of the National Academy of Sciences 109 (41), 16570-16575, 2012
1542012
The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs
M Boi, E Gaudio, P Bonetti, I Kwee, E Bernasconi, C Tarantelli, A Rinaldi, ...
Clinical Cancer Research 21 (7), 1628-1638, 2015
1402015
Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer
L Cascione, P Gasparini, F Lovat, S Carasi, A Pulvirenti, A Ferro, H Alder, ...
PloS one 8 (2), e55910, 2013
1312013
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation
P Gasparini, F Lovat, M Fassan, L Casadei, L Cascione, NK Jacob, ...
Proceedings of the National Academy of Sciences 111 (12), 4536-4541, 2014
1212014
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
P Gasparini, L Cascione, M Fassan, F Lovat, G Guler, S Balci, C Irkkan, ...
Oncotarget 5 (5), 1174, 2014
1172014
Regulation of acute graft-versus-host disease by microRNA-155
P Ranganathan, CEA Heaphy, S Costinean, N Stauffer, C Na, ...
Blood 119 (20), 4786-4797, 2012
1142012
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
F Pichiorri, D Palmieri, L De Luca, J Consiglio, J You, A Rocci, T Talabere, ...
Journal of Experimental Medicine 210 (5), 951-968, 2013
862013
Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options
P Gasparini, M Fassan, L Cascione, G Guler, S Balci, C Irkkan, C Paisie, ...
PLoS One 9 (2), e88525, 2014
612014
miR-15b/16-2 deletion promotes B-cell malignancies
F Lovat, M Fassan, P Gasparini, L Rizzotto, L Cascione, M Pizzi, ...
Proceedings of the National Academy of Sciences 112 (37), 11636-11641, 2015
602015
Circulating miRNA markers show promise as new prognosticators for multiple myeloma
A Rocci, CC Hofmeister, S Geyer, A Stiff, M Gambella, L Cascione, J Guan, ...
Leukemia 28 (9), 1922, 2014
54*2014
The genetics of nodal marginal zone lymphoma
V Spina, H Khiabanian, M Messina, S Monti, L Cascione, A Bruscaggin, ...
Blood 128 (10), 1362-1373, 2016
512016
microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers
P Gasparini, L Cascione, L Landi, S Carasi, F Lovat, C Tibaldi, G Alý, ...
Proceedings of the National Academy of Sciences 112 (48), 14924-14929, 2015
472015
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies
A Drusco, A Bottoni, A Lagana, M Acunzo, M Fassan, L Cascione, ...
Oncotarget 6 (25), 20829, 2015
472015
Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression
R Galli, A Paone, M Fabbri, N Zanesi, F Calore, L Cascione, M Acunzo, ...
Proceedings of the National Academy of Sciences 110 (24), 9812-9817, 2013
472013
A MALT lymphoma prognostic index
C Thieblemont, L Cascione, A Conconi, B Kiesewetter, M Raderer, ...
Blood 130 (12), 1409-1417, 2017
452017
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
H Janouskova, G El Tekle, E Bellini, ND Udeshi, A Rinaldi, A Ulbricht, ...
Nature medicine 23 (9), 1046, 2017
442017
TWIST1-induced miR-424 reversibly drives mesenchymal programming while inhibiting tumor initiation
DJ Drasin, AL Guarnieri, D Neelakantan, J Kim, JH Cabrera, CA Wang, ...
Cancer research 75 (9), 1908-1921, 2015
432015
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features
AJ Arribas, A Rinaldi, AA Mensah, I Kwee, L Cascione, EF Robles, ...
Blood 125 (12), 1922-1931, 2015
412015
The system can't perform the operation now. Try again later.
Articles 1–20